MLYS
Mineralys Therapeutics, Inc.
25.60$
-0.9%
vs. previous close
Closing price · As of: Sep 28, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| – | +648.7% | +928.7% | +119.9% | -18.2% | +221.4% | |
| – | +658.7% | +914.3% | +120.8% | -17.6% | +222.1% | |
| – | +653.2% | +726.4% | -43.8% | +131.4% | +51.6% | |
| – | +653.2% | +937.6% | +114.8% | -16.2% | +231.3% | |
| – | +569.9% | +389.6% | -93.7% | +39.7% | +3.2% | |
| – | -0.6% | +59.6% | +29.9% | +39.7% | +3.2% | |
| – | – | – | – | – | – | |
| – | +44.2% | +149.9% | -68.5% | -20.3% | +321.1% | |
| – | – | – | – | -20.7% | +238.1% | |
| – | – | – | – | – | – | |
| – | +7.6% | +3.7% | +600.3% | +34.1% | +39.4% |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.